Position in GILD
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$1,951,700
+$1,516,647 QoQ
Shares Held
15,448
+293.7% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.52%
of 13F equity value
Holder Rank
#841
of 2,266 holders
Holding Since
Jun 2021
6 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in GILD Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Bridgefront Capital, LLC holds $6,932,010 across 7 Drug Manufacturers - General names. GILD ranks #2 (28.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
7,888 | $2,003,315 | |
| 2 | GILD |
Gilead Sciences, Inc.
This page
|
15,448 | $1,951,700 | |
| 3 | PFE |
Pfizer Inc
|
59,596 | $1,435,071 | |
| 4 | LLY |
ELI LILLY & Co
|
467 | $560,133 | |
| 5 | NVS |
Novartis AG
|
3,062 | $479,876 | |
| 6 | GSK |
GSK plc
|
6,458 | $338,528 | |
| 7 | OGN |
Organon & Co.
|
12,067 | $163,387 |
All Filings in GILD
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,951,700 | 15,448 | Shares | Sole | 2026-08-14 | |
| 2025-06-30 | $435,053 | 3,924 | Shares | Sole | 2025-08-14 | |
| 2024-03-31 | $690,308 | 9,424 | Shares | Sole | 2024-05-15 | |
| 2023-06-30 | $453,942 | 5,890 | Shares | Sole | 2023-08-14 | |
| 2022-06-30 | $220,290 | 3,564 | Shares | Sole | 2022-08-12 | |
| 2021-06-30 | $278,125 | 4,039 | Shares | Sole | 2021-08-12 | |
| No filing history on record for this holder in this stock. | ||||||